A New Treatment Option for Patients with cGVHD
Science & Innovation Webinar
Webinar Recorded on Aug. 24, 2021
Sponsored by Kadmon
The focus of this webinar is the introduction of a new treatment for chronic graft-versus-host disease (cGVHD), a complication that can occur following allogeneic stem cell transplantation, resulting in significant morbidity and mortality.
- Jonathan Ieyoub, MS, NP-C
VP, Head of Medical Affairs
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.